StocksMediumUpdated•Originally published 17 November 2026•Updated 17 November 2026•
1 min read
SELLAS Life Sciences Shares Fall After Announcing $150 Million Stock Offering
Key Facts
1SELLAS Life Sciences announced the commencement of an underwritten public offering of $150.0 million of its common stock.
2The company intends to grant underwriters a 30-day option to purchase up to an additional $22.5 million of shares.
SELLAS Life Sciences stock price declined following the company's announcement of an underwritten public offering of $150.0 million of its common stock. GlobeNewswire reported that the company intends to grant underwriters a 30-day option to purchase up to an additional $22.5 million of shares under the same terms and conditions.
The company plans to use the proceeds for the clinical development of cancer therapies and general corporate purposes. SLS was trading at $7.47 on November 16, 2026, after reaching a session high of $8.39 and a low of $7.24.